Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc (XTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,422
  • Shares Outstanding, K 130,110
  • Annual Sales, $ 57,970 K
  • Annual Income, $ -8,490 K
  • 60-Month Beta 0.20
  • Price/Sales 1.70
  • Price/Cash Flow N/A
  • Price/Book 2.45
Trade XTNT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +249,850.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9300 +26.34%
on 03/25/24
1.2999 -9.61%
on 02/29/24
-0.0950 (-7.48%)
since 02/28/24
3-Month
0.9050 +29.83%
on 01/17/24
1.3100 -10.31%
on 01/04/24
-0.0250 (-2.08%)
since 12/28/23
52-Week
0.5600 +109.82%
on 03/30/23
1.4500 -18.97%
on 12/05/23
+0.4990 (+73.82%)
since 03/28/23

Most Recent Stories

More News
Xtant Medical Announces Second Quarter 2022 Financial Results

BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical Announces First Quarter 2022 Financial Results

BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical Appoints Scott Neils as Chief Financial Officer

BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022

BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results

BELGRADE, Mont., March 08, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer

BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)
Xtant Medical Announces Third Quarter 2021 Financial Results

BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 1.1700 (+5.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Key Turning Points

3rd Resistance Point 1.2567
2nd Resistance Point 1.2033
1st Resistance Point 1.1567
Last Price 1.1700
1st Support Level 1.0567
2nd Support Level 1.0033
3rd Support Level 0.9567

See More

52-Week High 1.4500
Last Price 1.1700
Fibonacci 61.8% 1.1100
Fibonacci 50% 1.0050
Fibonacci 38.2% 0.9000
52-Week Low 0.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar